[Federal Register Volume 88, Number 61 (Thursday, March 30, 2023)]
[Rules and Regulations]
[Page 18987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06701]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Part 240


General Rules and Regulations, Securities Exchange Act of 1934

CFR Correction

    This rule is being published by the Office of the Federal Register 
to correct an editorial or technical error that appeared in the most 
recent annual revision of the Code of Federal Regulations.

0
In Title 17 of the Code of Federal Regulations, Part 240, revised as of 
April 1, 2022, in section 240.13e-100, reinstate the paragraphs at the 
end of the section following ``Item 16. Exhibits'' to read as follows:


Sec.  240.13e-100  Schedule 13E-3, Transaction statement under section 
13(e) of the Securities Exchange Act of 1934 and Rule 13e-3 (Sec.  
240.13e-3) thereunder.

* * * * *
    Signature. After due inquiry and to the best of my knowledge and 
belief, I certify that the information set forth in this statement is 
true, complete and correct.

-----------------------------------------------------------------------
(Signature)

-----------------------------------------------------------------------
(Name and title)

-----------------------------------------------------------------------
(Date)

    Instruction to Signature: The statement must be signed by the 
filing person or that person's authorized representative. If the 
statement is signed on behalf of a person by an authorized 
representative (other than an executive officer of a corporation or 
general partner of a partnership), evidence of the representative's 
authority to sign on behalf of the person must be filed with the 
statement. The name and any title of each person who signs the 
statement must be typed or printed beneath the signature. See Sec.  
240.12b-11 with respect to signature requirements.

[FR Doc. 2023-06701 Filed 3-29-23; 8:45 am]
BILLING CODE 0099-10-P